<!DOCTYPE HTML>
<!DOCTYPE html PUBLIC "" ""><HTML lang="en" lang="en" xml:lang="en" xmlns="http://www.w3c.org/1999/xhtml"><HEAD><META 
content="IE=11.0000" http-equiv="X-UA-Compatible">
     
<META http-equiv="content-type" content="text/html; charset=utf-8">     
<TITLE>P_GLU</TITLE>     
<META name="title" content="NHANES 2017-March 2020: Plasma Fasting Glucose Data Documentation, Codebook, and Frequencies"> 
    
<STYLE type="text/css">
					.nhanes-doc { font: 75% Verdana, Arial, Helvetica, sans-serif; }

					.nhanes-doc h1 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 2em;
					font-weight: normal;
					margin-bottom: 10px;
					margin-top: 0;
					}

					.nhanes-doc h2 {
					color: #0c5205;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.6em;
					font-weight: normal;
					}

					.nhanes-doc h3 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.5em;
					font-weight: normal;
					}

					.nhanes-doc h3.vartitle {
					background-color: #c1d5b0;
					padding: 6px 12px;
					}

					.nhanes-doc h4 {
					color: #000;
					font-family: "Trebuchet MS", Arial, sans-serif;
					font-size: 1.3em;
					font-weight: bold;
					}

					.nhanes-doc h5 {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					font-weight: bold;
					}

					.nhanes-doc h5.specialnote {
					color: #000;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1.2em;
					font-style: italic;
					font-weight: bold;
					}

					.nhanes-doc a {
					color: #039;
					text-decoration: none;
					}

					.nhanes-doc p {
					font-family: Verdana, Arial, Helvetica, sans-serif;
					font-size: 1em;
					line-height: 1.33em;
					margin: 0 3em 1em;
					padding: 0;
					text-align: left;
					}

					.nhanes-doc ul {
					list-style-type: disc;
					margin: 0 3em 1em;
					padding: 0;
					}

					.nhanes-doc ol {
					list-style-type: decimal;
					margin: 0;
					overflow: hidden;
					padding: 0;
					padding-left: 2em;
					}

					.nhanes-doc li {
					margin-left: 1.5em;
					margin-top: 0.7em;
					}

					.nhanes-doc table {
					border: #000 1px solid;
					border-collapse: collapse;
					margin: 0 auto 1em;
					max-width: 600px;
					padding: 2px;
					page-break-inside: avoid;
					table-layout: auto;
					}

					.nhanes-doc th {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc th.rowheader {
					background: #f4f4e1;
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: center;
					vertical-align: top;
					}

					.nhanes-doc td {
					border: #000 1px solid;
					font-family: Verdana, Arial, Helvetica, sans-serif;
					padding: 5px;
					text-align: left;
					vertical-align: top;
					}

					.nhanes-doc td p {
					margin: inherit;
					}

					.nhanes-doc td.values2 {
					text-align: RIGHT;
					vertical-align: top;
					}

					.nhanes-doc table caption {
					font-weight: bold;
					padding-bottom: 0.5em;
					}

					.nhanes-doc div#wrapper { width: 650px; }

					.nhanes-doc div#toc {
					border: solid 1px #CCC;
					float: left;
					height: 95%;
					left: 750px;
					overflow: hidden;
					position: fixed;
					top: 10px;
					width: 400px;
					z-index: 10;
					}

					.nhanes-doc div#toc h3 {
					background-color: #f4f4e1;
					border-bottom: solid 1px #ccc;
					letter-spacing: 8px;
					margin: 0;
					padding: 8px;
					text-align: center;
					text-transform: uppercase;
					}

					.nhanes-doc div#toc-scroll {
					height: calc(100% - 1.5em);
					overflow: scroll;
					width: 100%;
					}

					.nhanes-doc div#toc li {
					margin-left: -0.5em;
					margin-right: -0.5em;
					}

					.nhanes-doc div#PageHeader {
					border-bottom: thin solid #999;
					margin-bottom: 12px;
					width: 650px;
					}

					.nhanes-doc div#Sections { width: 650px; }

					.nhanes-doc div#Codebook { width: 650px; }

					.nhanes-doc div#Codebook dl {
					margin: 2em 0 10px 40px;
					padding: 0;
					width: 600px;
					display: table;
					}

					.nhanes-doc div#Codebook dt {
					float: left;
					font-weight: bold;
					margin: 0;
					padding: 0.5em;
					width: 150px;
					display: table-cell;
					}

					.nhanes-doc div#Codebook dd {
					float: left;
					margin: 0;
					padding: 0.5em;
					width: 420px;
					display: table-cell;
					}

					.nhanes-doc div#References {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc div#References li {
					word-wrap: break-word;
					}

					.nhanes-doc div#Appendix {
					page-break-after: always;
					width: 650px;
					}

					.nhanes-doc table.values {
					border: 2px;
					left: 20px;
					margin-bottom: 20px;
					page-break-inside: avoid;
					position: relative;
					width: 600px;
					}

					.nhanes-doc span.file-size { color: gray; }

					.nhanes-doc .pagebreak {
					background-color: transparent;
					display: block;
					page-break-after: always;
					page-break-inside: avoid;
					}
				</STYLE>
     
<STYLE type="text/css" media="print">
					.nhanes-doc div#toc { display: none; }
				</STYLE>
   
<META name="GENERATOR" content="MSHTML 11.00.10570.1001"></HEAD>   
<BODY class="nhanes-doc">
<DIV id="toc">
<H3>Table of Contents</H3>
<DIV id="toc-scroll">
<UL>
  <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#Component_Description">Component 
  Description</A>           </LI>
  <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#Eligible_Sample">Eligible 
  Sample</A>           </LI>
  <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#Description_of_Laboratory_Methodology">Description 
  of Laboratory Methodology</A>           </LI>
  <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#Laboratory_Method_Files">Laboratory 
  Method Files</A>           </LI>
  <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#Laboratory_Quality_Assurance_and_Monitoring">Laboratory 
  Quality Assurance and Monitoring</A>           </LI>
  <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#Data_Processing_and_Editing">Data 
  Processing and Editing</A>           </LI>
  <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#Analytic_Notes">Analytic 
  Notes</A>           </LI>
  <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#References">References</A> 
            </LI>
  <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#Codebook">Codebook</A> 
              
  <UL id="CodebookLinks">
    <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#SEQN">SEQN 
    - Respondent sequence number</A>               </LI>
    <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#WTSAFPRP">WTSAFPRP 
    - Fasting Subsample Weight</A>               </LI>
    <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#LBXGLU">LBXGLU 
    - Fasting Glucose (mg/dL)</A>               </LI>
    <LI><A href="http://dspp-hane-1601/Nchs/Edit/DocumentationView.aspx?Id=7593&amp;Dataset=P_GLU#LBDGLUSI">LBDGLUSI 
    - Fasting Glucose (mmol/L)</A>               </LI></UL></LI></UL></DIV></DIV>
<DIV id="wrapper">
<DIV id="PageHeader">
<H1>National Health and Nutrition Examination Survey</H1>
<H2>2017-March 2020 Data Documentation, Codebook, and Frequencies</H2>
<H3>Plasma Fasting Glucose (P_GLU)</H3>
<H4> Data File: P_GLU.xpt</H4>
<H5 class="left">First Published: May 2021</H5>
<H5 class="right">Last Revised: NA</H5></DIV>
<DIV id="Sections">
<H2 id="Component_Description">Component Description</H2>
<P>The NHANES program suspended field operations in March 2020 due to the 
coronavirus disease 2019 (COVID-19) pandemic. As a result, data collection for 
the NHANES 2019-2020 cycle was not completed and the collected data are not 
nationally representative. Therefore, data collected from 2019 to March 2020 
were combined with data from the NHANES 2017-2018 cycle to form a nationally 
representative sample of NHANES 2017-March 2020 pre-pandemic data. These data 
are available to the public. Please refer to the Analytic Notes section for more 
details on the use of the data.</P>
<P>In 2015, diabetes was the seventh leading cause of death in the United 
States. More than 30 million Americans are living with diabetes, and 86 million 
are living with prediabetes, which is a serious health condition that increases 
a person’s risk of type-2 diabetes and other chronic diseases. The prevalence of 
diabetes and overweight (one of the major risk factors for diabetes) continues 
to increase. Substantial new efforts to prevent or control diabetes have begun, 
including the Diabetes Prevention Trial and the National Diabetes Education 
Program.</P>
<P>Diabetes testing provides population data to: 1) determine a national 
estimate of diabetes prevalence (diagnosed and undiagnosed); 2) identify the 
risk factors; 3) permit a national cohort to be established for follow-up 
studies of this condition; and 4) provide critical information to clinicians and 
public health officials for the development of preventive care and 
community-based interventions.</P>
<H2 id="Eligible_Sample">Eligible Sample</H2>
<P>All examined participants 12 years and older in the NHANES 2017-March 2020 
pre-pandemic sample were eligible.</P>
<H2 id="Description_of_Laboratory_Methodology">Description of Laboratory 
Methodology</H2>
<P><STRONG>Glucose </STRONG><BR>In this enzymatic method glucose is converted to 
glucose-6-phosphate (G-6-P) by hexokinase in the presence of ATP, a phosphate 
donor. Glucose-6-phosphate dehydrogenase then converts the G-6-P to 
gluconate-6-P in the presence of NADP+. As the NADP+ is reduced to NADPH during 
this reaction, the resulting increase in absorbance at 340 nm (secondary 
wavelength = 700 nm) is measured. This is an endpoint reaction that is specific 
for glucose. </P>
<P>Refer to the Laboratory Method Files section for a detailed description of 
the laboratory methods used. </P>
<H2 id="Laboratory_Method_Files">Laboratory Method Files</H2>
<P><A href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/labmethods/GLU-J-MET-508.pdf" 
target="_blank">Plasma Fasting Glucose Laboratory Procedure Manual</A>           
<SPAN> (August 2020)</SPAN>         </P>
<P><A href="https://wwwn.cdc.gov/nchs/data/nhanes/2019-2020/labmethods/GLU-K-MET-508.pdf" 
target="_blank">Plasma Fasting Glucose Laboratory Procedure Manual	</A>          
 <SPAN> (April 2021)</SPAN>         </P>
<H2 id="Laboratory_Quality_Assurance_and_Monitoring">Laboratory Quality 
Assurance and Monitoring</H2>
<P>Plasma specimens are processed, stored, and shipped to the University of 
Missouri-Columbia, Columbia, MO for analysis.</P>
<P>Detailed instructions on specimen collection and processing are discussed in 
the NHANES <A href="https://wwwn.cdc.gov/nchs/data/nhanes/2017-2018/manuals/2017_MEC_Laboratory_Procedures_Manual.pdf">2017-2018</A> 
and <A href="https://wwwn.cdc.gov/nchs/data/nhanes/2019-2020/manuals/2020-MEC-Laboratory-Procedures-Manual-508.pdf">2019-2020 
Laboratory Procedures Manuals</A>&nbsp;(LPM). Vials are stored under appropriate 
frozen (–30°C) conditions until they are shipped to University of 
Missouri-Columbia for testing.</P>
<P>The NHANES quality assurance and quality control (QA/QC) protocols meet the 
1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions 
are discussed in the NHANES LPM.</P>
<P><STRONG>Mobile Examination Centers (MECs) </STRONG></P>
<P>Laboratory team performance is monitored using several techniques. NCHS and 
contract consultants use a structured competency assessment evaluation during 
visits to evaluate both the quality of the laboratory work and the QC 
procedures. Each laboratory staff member is observed for equipment operation, 
specimen collection and preparation; testing procedures and constructive 
feedback are given to each staff member. Formal retraining sessions are 
conducted annually to ensure that required skill levels were maintained.</P>
<P><STRONG>Analytical Laboratories</STRONG></P>
<P>NHANES uses several methods to monitor the quality of the analyses performed 
by the contract laboratories. In the MEC, these methods include performing blind 
split samples collected on “dry run” sessions. In addition, contract 
laboratories randomly perform repeat testing on 2% of all specimens.</P>
<P>NCHS developed and distributed a QC protocol for all CDC and contract 
laboratories, which outlined the use of Westgard rules (Westgard et al, 1981) 
when testing NHANES specimens. Progress reports containing any problems 
encountered during shipping or receipt of specimens, summary statistics for each 
control pool, QC graphs, instrument calibration, reagents, and any special 
considerations are submitted to NCHS quarterly. The reports are reviewed for 
trends or shifts in the data. The laboratories are required to explain any 
identified areas of concern.</P>
<H2 id="Data_Processing_and_Editing">Data Processing and Editing</H2>
<P>The data were reviewed. Incomplete data or improbable values were sent to the 
performing laboratory for confirmation. <BR><BR>One variable was created in this 
data file. The variable was created using the following formulas: 
<BR><BR><STRONG>LBXGLU and LBDGLUSI:</STRONG> <BR>The fasting glucose value in 
mg/dL (LBXGLU) was converted to mmol/L (LBDGLUSI) by multiplying by 0.05551 
(rounded to 3 decimals).</P>
<H2 id="Analytic_Notes">Analytic Notes</H2>
<P>The COVID-19 pandemic required suspension of NHANES 2019-2020 field 
operations in March 2020 after data were collected in 18 of the 30 survey 
locations in the 2019-2020 sample. Data collection was cancelled for the 
remaining 12 locations. Because the collected data from 18 locations were not 
nationally representative, these data were combined with data from the previous 
cycle (2017-2018) to create a 2017-March 2020 pre-pandemic data file. A special 
weighting process was applied to the 2017-March 2020 pre-pandemic data file. The 
resulting sample weights in the present file should be used to calculate 
estimates from the combined cycles. These sample weights are not appropriate for 
independent analyses of the 2019-2020 data and will not yield nationally 
representative results for either the 2017-2018 data alone or the 2019-March 
2020 data alone. Please refer to the NHANES website for additional information 
for the NHANES 2017-March 2020 pre-pandemic data, and for the previous 2017-2018 
public use data file with specific weights for that 2-year cycle. </P>
<P>Refer to the <A href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2017">2017-2018</A> 
and <A href="https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/overviewlab.aspx?BeginYear=2019">2019-2020 
Laboratory Data Overview</A>&nbsp;documents for general information on NHANES 
laboratory data.</P>
<P>There are over 800 laboratory tests performed on NHANES participants.
 However, not all participants provided biospecimens or enough volume for all
 the tests to be performed. The specimen availability can also vary by age or
 other population characteristics. For example, in 2017-March 2020,
 approximately 76% of children aged 1-17 years who were examined in the MEC
 provided a blood specimen through phlebotomy, while 95% of examined adults age
 18 and older provided a blood specimen. &nbsp;Analysts should evaluate the 
extent of missing data in the dataset related to the outcome of interest as well 
as any predictor variables used in the analyses to determine whether additional 
re-weighting for item non-response is necessary. </P>
<P>Please refer to the NHANES <A href="https://wwwn.cdc.gov/nchs/nhanes/analyticguidelines.aspx">Analytic
 Guidelines</A> and the on-line NHANES <A href="https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx">Tutorial 
</A>for further details on the use of sample weights and other analytic 
issues.</P>
<P><STRONG>Subsample Weights</STRONG><BR><BR>Glucose was measured in a fasting 
subsample of participants 12 years and older. Specific sample weights (WTSAFPRP) 
for this subsample are included in this data file and should be used when
 analyzing these data. Participants included in the fasting subsample but did
 not provide a blood specimen (n=346) have an assigned sample weight value of 
“0” in their records. In addition, participants whom provided blood specimen but 
did not meet the 8 to less than 24 hour fasting criteria (n=268) have the sample 
weight value assigned as “0” (WTSAFPRP=0) as well. Glucose measurements for 
these&nbsp;268 participants are included in the dataset. However, to include 
these data in the analysis, a reweighting would be required. 
<BR><BR><STRONG>Demographic and Other Related Variables</STRONG></P>
<P>The analysis of NHANES laboratory data must be conducted using the 
appropriate survey design and demographic variables. The NHANES <A href="https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Demographics&amp;Cycle=2017-2020">2017-March 
2020 Pre-Pandemic Demographics File</A> contains demographic data, health 
indicators, and other related information collected during household interviews 
as well as the sample design variables. The recommended procedure for variance 
estimation requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, 
respectively) in the demographic data file.</P>
<P>In the 2017-March pre-pandemic NHANES cycle, the variables PHAFSTHR (total 
length of “food fast”, hours) and PHAFSTMN (Total length of “food fast”, 
minutes) will not be reported in this file. PHAFSTHR and PHAFSTMN can be found 
in the <A href="https://wwwn.cdc.gov/Nchs/Nhanes/2017-2018/P_FASTQX.htm">Fasting 
Questionnaire File</A> (P_FASTQX). The fasting questionnaire data file also 
includes additional auxiliary information such as fasting status, and the time 
of venipuncture.&nbsp; </P>
<P>This laboratory data file can be linked to the other NHANES data files using 
the unique survey participant identifier (i.e., SEQN).</P>
<P><STRONG>Detection Limits</STRONG></P>
<P>The detection limits were constant for all of the analytes in the data set. 
Two variables are provided for each of these analytes. The variable name ending 
“LC” (ex., LBDGLULC<EM>) </EM>indicates whether the result was below the limit 
of detection: the value “0” means that the result was at or above the limit of 
detection, “1” indicates that the result was below the limit of detection. The 
other variable prefixed LBX (ex., LBXGLU<EM>) </EM>provides the analytic result 
for that analyte.&nbsp; For analytes with analytic results below the lower limit 
of detection (ex., LBDGLULC=1), an imputed fill value was placed in the analyte 
results field. This value is the lower limit of detection divided by the square 
root of 2 (LLOD/sqrt[2]). </P>
<P>The lower limit of detection (LLOD, in mg/dL) for fasting glucose: </P>
<TABLE width="462" border="1" cellspacing="0" cellpadding="0">
  <TBODY>
  <TR>
    <TD valign="top" style="width: 138px; text-align: left;">
      <P><STRONG>Variable Name</STRONG></P></TD>
    <TD valign="top" style="width: 174px; text-align: left;">
      <P><STRONG>Analyte            Description</STRONG></P></TD>
    <TD valign="top" style="width: 150px; text-align: left;">
      <P>&nbsp;<STRONG>LLOD</STRONG></P></TD></TR>
  <TR>
    <TD valign="top" style="width: 138px; text-align: left;">
      <P>LBXGLU</P></TD>
    <TD valign="top" style="width: 174px; text-align: left;">
      <P>Fasting glucose</P></TD>
    <TD valign="top" style="width: 150px; text-align: left;">
      <P>&nbsp;2.0</P></TD></TR></TBODY></TABLE>
<P><STRONG>Comparability with previous cycles&nbsp;</STRONG><BR></P>
<P>There were equipment changes during the 2015-2016, 2007-2008, and 2005-2006 
survey cycles. For analysis involving 2015-2016 data and data collected prior to 
2007-2008 cycle, please refer to the documentation accompanying those data for 
additional information on any needed adjustments to the data prior to analysis. 
If 2017-March 2020 pre-pandemic data are compared or combined with the 2015-2016 
data, no adjustments are needed for equipment changes. As mentioned in the 
2015-2016 documentation, most of the 2015-2016 samples were measured using the 
Cobas C311, which is the same instrument used in 2017-2018. Some of the samples 
were collected using the Cobas C501. Results for these specimens have already 
been adjusted using the forward regression equation for comparability. Please 
see the 2015-2016 fasting plasma glucose documentation for more information 
about using backwards or forwards regression models to account for equipment 
changes between cycles (include link to documentation here).</P></DIV>
<DIV id="References">
<H2>References</H2>
<UL>
  <LI>Westgard J.O., Barry P.L., Hunt M.R., Groth T. A multi-rule Shewhart chart 
  for quality control in clinical chemistry. Clin Chem (1981) 
27:493-501.</LI></UL></DIV>
<DIV id="Codebook">
<H2>Codebook and Frequencies</H2>
<DIV class="pagebreak">
<H3 class="vartitle" id="SEQN">SEQN - Respondent sequence number</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">SEQN</DD>
  <DT>SAS Label: </DT>
  <DD>Respondent sequence number</DD>
  <DT>English Text: </DT>
  <DD class="info">Respondent sequence number</DD>
  <DT>Target: </DT>
  <DD> Both males and females 12 YEARS -			150 YEARS</DD></DL></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="WTSAFPRP">WTSAFPRP - Fasting Subsample Weight</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">WTSAFPRP</DD>
  <DT>SAS Label: </DT>
  <DD>Fasting Subsample Weight</DD>
  <DT>English Text: </DT>
  <DD class="info">Fasting Subsample Weight</DD>
  <DT>Target: </DT>
  <DD> Both males and females 12 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">4808.069916 to 741259.18875</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">4476</TD>
    <TD align="right" class="values">4476</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">0</TD>
    <TD class="values">No Lab Result or Not Fasting for 8 -&lt; 24 Hours</TD>
    <TD align="right" class="values">614</TD>
    <TD align="right" class="values">5090</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">0</TD>
    <TD align="right" class="values">5090</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="LBXGLU">LBXGLU - Fasting Glucose (mg/dL)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">LBXGLU</DD>
  <DT>SAS Label: </DT>
  <DD>Fasting Glucose (mg/dL)</DD>
  <DT>English Text: </DT>
  <DD class="info">Fasting Glucose (mg/dL)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 12 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">47 to 524</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">4744</TD>
    <TD align="right" class="values">4744</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">346</TD>
    <TD align="right" class="values">5090</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV>
<DIV class="pagebreak">
<H3 class="vartitle" id="LBDGLUSI">LBDGLUSI - Fasting Glucose (mmol/L)</H3>
<DL>
  <DT>Variable Name: </DT>
  <DD class="info">LBDGLUSI</DD>
  <DT>SAS Label: </DT>
  <DD>Fasting Glucose (mmol/L)</DD>
  <DT>English Text: </DT>
  <DD class="info">Fasting Glucose (mmol/L)</DD>
  <DT>Target: </DT>
  <DD> Both males and females 12 YEARS -			150 YEARS</DD></DL>
<TABLE class="values">
  <THEAD>
  <TR>
    <TH class="values" scope="column">Code or Value</TH>
    <TH class="values" scope="column">Value Description</TH>
    <TH class="values" scope="column">Count</TH>
    <TH class="values" scope="column">Cumulative</TH>
    <TH class="values" scope="column">Skip to Item</TH></TR></THEAD>
  <TBODY>
  <TR>
    <TD class="values" scope="row">2.61 to 29.1</TD>
    <TD class="values">Range of Values</TD>
    <TD align="right" class="values">4744</TD>
    <TD align="right" class="values">4744</TD>
    <TD class="values"></TD></TR>
  <TR>
    <TD class="values" scope="row">.</TD>
    <TD class="values">Missing</TD>
    <TD align="right" class="values">346</TD>
    <TD align="right" class="values">5090</TD>
    <TD class="values"></TD></TR></TBODY></TABLE></DIV></DIV></DIV></BODY></HTML>
